Beyond heparin and warfarin: the new generation of anticoagulants.
about
Chemoenzymatic synthesis of heparan sulfate and heparinFactor XI-deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosisTriggers, targets and treatments for thrombosis.In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release.Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparinsSynthesis and anticoagulant activity of polyureas containing sulfated carbohydratesHomogeneous low-molecular-weight heparins with reversible anticoagulant activity.Efficacy and safety of fondaparinux in patients with acute coronary syndromes.Novel factor Xa inhibitors: a patent review.Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions.Novel serine protease inhibitors.Synthetic oligosaccharides as active pharmaceutical ingredients: lessons learned from the full synthesis of one heparin derivative on a large scale.Use of Molecular Dynamics for the Refinement of an Electrostatic Model for the In Silico Design of a Polymer Antidote for the Anticoagulant Fondaparinux.Evaluation of anticoagulation selection for acute venous thromboembolism.Total synthesis of anticoagulant pentasaccharide fondaparinux.Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin.Novel venous thromboembolic disease (VTED) prophylaxis for total knee arthroplasty-aspirin and fish oil.Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides.
P2860
Q27005958-0C38E2E8-9682-4852-80DC-207047E013F2Q33397684-229A24E3-2AA6-41B2-B883-FAA379928347Q33765444-A7254C7B-022C-4355-BBB0-F6F2763BF52EQ33894433-11B78A68-62F4-4DAE-9A30-B82C1CA2E4F5Q34228210-BFA726ED-5328-442E-BCB4-9C44E497A0B3Q34669693-D3B2D6F6-D4AF-4A3C-9999-0D08212BEEDEQ35361517-63AC3CE4-AF25-4749-B2FF-93EBC3BA547AQ37012898-4DB6D689-44FE-4D18-B4E3-519387C96A24Q37594779-B0AC594F-ECD1-4991-9DA4-1851F00BA4E6Q38108855-97C0DA93-3FA8-4A1B-B95A-F711AD940C05Q38162937-FA826FE2-AED0-42CB-BDE6-B232645C1D93Q38202512-98470004-F3A0-4212-A3CB-2D6142FCCC30Q38840652-EF11459F-C0C2-46C9-A380-B099C9338276Q39424848-4314EA4B-23DA-4969-A7CE-2D7A220BD5A3Q46054925-892C7A9B-A2CF-4E20-9C37-B6BDF1A157A6Q46403531-71752881-015B-414D-8C2B-E4AD71DD8AC9Q47390382-A9EAE082-4D24-4356-993C-3C1A58AD6805Q53094376-F37BB006-F813-4F07-9835-59B6EF7F978D
P2860
Beyond heparin and warfarin: the new generation of anticoagulants.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Beyond heparin and warfarin: the new generation of anticoagulants.
@ast
Beyond heparin and warfarin: the new generation of anticoagulants.
@en
type
label
Beyond heparin and warfarin: the new generation of anticoagulants.
@ast
Beyond heparin and warfarin: the new generation of anticoagulants.
@en
prefLabel
Beyond heparin and warfarin: the new generation of anticoagulants.
@ast
Beyond heparin and warfarin: the new generation of anticoagulants.
@en
P2860
P1476
Beyond heparin and warfarin: the new generation of anticoagulants.
@en
P2093
Jeffrey I Weitz
Lori-Ann Linkins
P2860
P304
P356
10.1517/13543784.16.3.271
P407
P577
2007-03-01T00:00:00Z